Literature DB >> 32940786

Effects of rhythmic auditory stimulation on upper-limb movement speed in patients with schizophrenia spectrum disorders.

Shu-Mei Wang1, Chung-Ying Lin2, Tracy Ho-Yan Tse3, Hin-Lun Chu4, Cheong-Ho Liu4, Tsz-Ho Ng4, Chun-Kwok Tse4, Wai-Man Wong4, Sunny Ho-Wan Chan4.   

Abstract

Movement slowness, linked to dysfunctional basal ganglia and cerebellum, is prevalent but lacks effective therapy in patients with schizophrenia spectrum disorders. This study was to examine immediate effects of rhythmic auditory stimulation (RAS) on upper-limb movement speed in patients. Thirty patients and 30 psychiatrically healthy people executed the right-hand task and the both-hand task of the Purdue Pegboard Test when listening to RAS with two tempi: normal (equal to the fastest movement tempo for each participant without RAS) and fast (120% of the normal tempo). The testing order of the RAS tempi for each participant was randomized. Patients had lower scores of right-hand and both-hand tasks than did psychiatrically healthy people. Scores of right-hand and both-hand tasks were higher in the fast-RAS condition than the normal-RAS condition in participants. This is the first study to explore the possibility of applying RAS to movement therapy for patients with schizophrenia spectrum disorders. The results demonstrated that faster RAS was effective in inducing faster upper-limb movements in patients and psychiatrically healthy people, suggesting that manipulating RAS may be a feasible therapeutic strategy utilized to regulate movement speed. The RAS may involve alternative neural pathways to modulate movement speed and thus to compensate for impaired function of basal ganglia and cerebellum in patients.
© 2020. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Auditory cue; Rhythmic auditory stimulation; Schizophrenia; Upper limb movement

Mesh:

Year:  2020        PMID: 32940786     DOI: 10.1007/s00406-020-01193-0

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  37 in total

Review 1.  Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review.

Authors:  S Pappa; P Dazzan
Journal:  Psychol Med       Date:  2008-11-12       Impact factor: 7.723

Review 2.  The role of the cerebellum in schizophrenia.

Authors:  Nancy C Andreasen; Ronald Pierson
Journal:  Biol Psychiatry       Date:  2008-04-08       Impact factor: 13.382

Review 3.  Motor symptoms and schizophrenia.

Authors:  Sebastian Walther; Werner Strik
Journal:  Neuropsychobiology       Date:  2012-07-17       Impact factor: 2.328

4.  Relationship between motor function and psychotic symptomatology in young-adult patients with schizophrenia.

Authors:  Shu-Mei Wang; Wen-Chen Ouyang; Ming-Yi Wu; Li-Chieh Kuo
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-04-11       Impact factor: 5.270

5.  Cross-Cutting Advancements Usher in a New Era for Motor Research in Psychosis.

Authors:  Vijay A Mittal
Journal:  Schizophr Bull       Date:  2016-08-18       Impact factor: 9.306

Review 6.  Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.

Authors:  C Mehler-Wex; P Riederer; M Gerlach
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 7.  Size of burden of schizophrenia and psychotic disorders.

Authors:  Wulf Rössler; Hans Joachim Salize; Jim van Os; Anita Riecher-Rössler
Journal:  Eur Neuropsychopharmacol       Date:  2005-08       Impact factor: 4.600

Review 8.  Motor system dysfunction in the schizophrenia diathesis: Neural systems to neurotransmitters.

Authors:  R Abboud; C Noronha; V A Diwadkar
Journal:  Eur Psychiatry       Date:  2017-04-25       Impact factor: 5.361

9.  Movement abnormalities predict conversion to Axis I psychosis among prodromal adolescents.

Authors:  Vijay A Mittal; Elaine F Walker
Journal:  J Abnorm Psychol       Date:  2007-11

Review 10.  Developmentally moderated expressions of the neuropathology underlying schizophrenia.

Authors:  E F Walker
Journal:  Schizophr Bull       Date:  1994       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.